AC Immune Reports Q3 Clinical Progress and CHF 73.9 Million Cash Resources
at www.tipranks.com (Wed, 4-Nov 7:28 AM)
AC Immune GAAP EPS of -CHF0.13, revenue of CHF3.24M
at seekingalpha.com (Wed, 4-Nov 7:26 AM)
